✉news HealthMedicine first seen 12 h ago, last 8 h ago, peak #37
EU Makes Pre-Submission Advice Permanent for Clinical Trials
Original: The EU Just Made Pre-Submission Advice Permanent. Your CTA Strategy Is Now Out of Date.
The European Union has made pre-submission regulatory advice a permanent feature of its clinical trial framework, ending what had been a temporary or optional mechanism. The change means sponsors designing clinical trial applications may need to rethink how they structure and time their submissions, since early advice from regulators will now be a fixed part of the process. Commentators in the clinical research field are urging sponsors to update their strategies accordingly.
Why now: Sponsors of clinical trials in the EU need to adjust their regulatory submission strategies following a formal change in the rules.
European Unionclinical trial sponsorsEU clinical trial regulators
Rank over time, top of the chart is #1. 4 snapshots from 12 h ago to 8 h ago.
Evidence
- The EU Just Made Pre-Submission Advice Permanent. Your CTA Strategy Is Now Out of Date. · The Clinical Trial Vanguard
API: https://socialmediatrends-api.osmike.com/v1/trends/1586984